AsPC-1 SMAD/TGFbeta Reporter (Luc) stable cell line
Catalog number
CL-1471
Description
AsPC-1 SMAD/TGFbeta Reporter (Luc) cells are derived from the human pancreas adenocarcinoma AsPC-1 cell line by stably integration of a SMAD/TGFbeta firefly luciferase reporter construct. AsPC-1 cell line has been widely used in cancer research and drug development. AsPC-1 SMAD/TGFbeta Reporter (Luc) cells stably express firefly luciferase under the control of the SMAD/TGFbeta response elements, can be used for monitoring the activity of TGFβ/SMAD signaling pathway.